Zhaoxing Chen

Zhaoxing Chen

Auto-generated profile, based on publicly available information

Zhaoxing Chen


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2021 in Medicine
Verified
Journal Article
Open access
MZMao Zhao
Mao Zhao
YJYuchang Jiang
Yuchang Jiang
ZCZhaoxing Chen
Zhaoxing Chen
ZFZhipeng Fan
Zhipeng Fan
YJYong Jiang
Yong Jiang
Background: Helicobacter pylori (Hp) is the only bacterium in the stomach. It is characterized by its ability to adhere to gastric mucosa and cause a series of pathological changes in the gastric mucosa. Modern research shows that Hp is an important pathogenic factor for chronic gastritis, gastroduodenal ulcer, and gastric cancer. Triple, quadruple, and triple combinations of antibacterial drugs, proton pump inhibitors, and bismuth aluminate preparations have been developed in modern medical research. Sequential therapy is used to treat Hp, but antibiotic resistance and repeated infections still exist. A large number of clinical trials have proved that traditional Chinese medicine has a good therapeutic effect on Hp. In this systematic review, we aim to evaluate the efficacy and safety of traditional Chinese medicine in the treatment of Hp. Methods and analysis: We will search for publications from Web of Science, PubMed, Science Direct, Wan Fang Data Knowledge Service Platform, Chinese Biomedical Literature Database (CBM), Chinese Scientific Journal Database (VIP database), China National Knowledge Infrastructure (CNKI) and EMBASE, which should be published from inception to December 2020. Two researchers will independently perform the selection of the studies, data extraction, and synthesis. The Cochrane Risk of Bias Tool will be used to evaluate the risk of bias in the randomized controlled trials. Statistical analysis will be performed by using the Cochrane Review Manager (RevMan 5.3) software. The I 2 test will be used to identify the extent of heterogeneity. We will use the Egger funnel chart to evaluate possible publication biases, in addition, when possible we will perform a subgroup/meta-regression analysis. The strength of the evidence will be assessed according to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE). Results and conclusions: This study will systematically evaluate the efficacy of traditional Chinese medicine in the treatment of Hp infection, and provide evidence for the clinical application of this treatment. The results of the research will be published in a peer-reviewed journal. Ethics: This systematic review will evaluate the efficacy of traditional Chinese medicine for Hp infection. Because all data used in this systematic review and meta-analysis have been published, this review does not require ethical approval. Trial registration number: INPLASY2020120057.

15 January 2021 in Medicine
Verified
Journal Article
Open access
SLSixuan Li
Sixuan Li
YYYing Ye
Ying Ye
ZCZhaoxing Chen
Zhaoxing Chen
MZMao Zhao
Mao Zhao
YJYuchang Jiang
Yuchang Jiang
YJYong Jiang
Yong Jiang
Background: As an alternative for salpingitis in IVF-ET, acupuncture has gradually attracted the attention of clinicians based on the theory of syndrome differentiation and treatment of Chinese traditional medicine. However, due to the lack of evidence-based medical evidence, the author designed the program to evaluate the effectiveness and safety of acupuncture. Methods: From the beginning to August 2020, 7 electronic databases will be searched. Two of our researchers will independently conduct research selection, data extraction, and risk assessment of bias. We will use Review Manager 5.3 software for meta-analysis and heterogeneity assessment. In addition, we will use the grading of recommendations assessment, development, and evaluation to evaluate the evidence quality. Results: This study will demonstrate an evidence-based review of acupuncture for salpingitis in IVF-ET. Conclusion: The study will provide clear evidence to assess the effectiveness and side effects of acupuncture for salpingitis in IVF-ET. Trial registration number: INPLASY2020110125.

8 January 2021 in Medicine
Verified
Journal Article
Open access
ZWZhaodi Wang
Zhaodi Wang
ZCZhaoxing Chen
Zhaoxing Chen
ZFZhipeng Fan
Zhipeng Fan
YJYong Jiang
Yong Jiang
Background: Liver cirrhosis is a common clinical chronic progressive disease. Due to the obstruction of blood flow after cirrhosis, it leads to long-term congestion of splenic sinus, hyperplasia of fibrous tissue and proliferation of splenic myeloid cells, resulting in hepatocirrhosis and splenomegaly. At present, western medicine still uses splenectomy and interventional therapy are the main treatment, but the adverse reactions are more and the curative effect is not good. Many clinical trials have proved that Traditional Chinese medicine has a great therapeutic effect on Hepatocirrhosis with splenomegaly, which can effectively delay the development of the disease and improve the survival rate of patients. This systematic review aims to evaluate the efficacy and safety of Traditional Chinese medicine in the treatment of hepatocirrhosis with splenomegaly. Methods: The databases of Pubmed, CENTRAL (The Cochrane Central Register of Controlled Trials), China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform (WANFANG Data), Weipu Information Chinese Periodical Service Platform (VIP), and China Biomedical Literature Service System (SinoMed) will be searched online to collect randomized controlled trials related to the treatment of hepatocirrhosis with splenomegaly with Traditional Chinese medicine The time is limited from the construction of the library to November 2020. We will use the criteria provided by Cochrane 5.1.0 for quality assessment and risk assessment of the included studies, and use the Revman 5.3 and Stata 13.0 software so as to systematically review the effectiveness of Traditional Chinese medicine for hepatocirrhosis with splenomegaly. Ethics and dissemination: This systematic review will evaluate the efficacy and safety of Traditional Chinese medicine for hepatocirrhosis with splenomegaly. Because all data used in this systematic review and meta-analysis have been published, this review does not require ethical approval. In addition, all data will be analyzed anonymously during the review process. Results: In this study, we will evaluate the efficacy of Traditional Chinese medicine in the treatment of cirrhosis with splenomegaly. Conclusion: The conclusion of this study will be evidence to ensure the efficacy of Traditional Chinese medicine© in the treatment of cirrhosis with splenomegaly and provide guidance for its treatment. Trial registration number: INPLASY2020110121.

10 December 2020
Verified
Report
Closed access
MZMao Zhao
Mao Zhao
YJYuchang Jiang
Yuchang Jiang
ZCZhaoxing Chen
Zhaoxing Chen
ZFZhipeng Fan
Zhipeng Fan
YJYong Jiang
Yong Jiang
INPLASY2020120057 Traditional Chinese Medicine for Helicobacter pylori infection: A protocol for a systematic review and meta-analysis Keywords: Helicobacter pylori; Traditional Chinese medicine; protocol; systematic review and meta-analysis. Download PDF – 2020120057